Home > > > Report Detail

Covid-19 Impact on Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 27-Apr-2020
No. of pages: 94
Inquire Before Buying

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.

The classification of ICAD (Intracranial Atherosclerotic Disease) Pathology includes Stent and PTA Balloon, and the proportion of Stent in 2017 is about 80.15%.

ICAD (Intracranial Atherosclerotic Disease) Pathology is widely used in Hospital, Clinic and other field. The most proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology is Hospital, and the consumption proportion in 2017 is about 63%.

North America is the largest Sales place, with a Sales market share nearly 26% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 20%.

Market competition is intense. Stryker, Balt, TERUMO, MicroPort, Acandis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the ICAD (Intracranial Atherosclerotic Disease) Pathology market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the ICAD (Intracranial Atherosclerotic Disease) Pathology industry.

Based on our recent survey, we have several different scenarios about the ICAD (Intracranial Atherosclerotic Disease) Pathology YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 159.9 million in 2019. The market size of ICAD (Intracranial Atherosclerotic Disease) Pathology will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global ICAD (Intracranial Atherosclerotic Disease) Pathology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global ICAD (Intracranial Atherosclerotic Disease) Pathology market in terms of revenue.

Players, stakeholders, and other participants in the global ICAD (Intracranial Atherosclerotic Disease) Pathology market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global ICAD (Intracranial Atherosclerotic Disease) Pathology market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global ICAD (Intracranial Atherosclerotic Disease) Pathology market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global ICAD (Intracranial Atherosclerotic Disease) Pathology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global ICAD (Intracranial Atherosclerotic Disease) Pathology market.

The following players are covered in this report:

- Stryker

- Balt

- TERUMO

- MicroPort

- Acandis

ICAD (Intracranial Atherosclerotic Disease) Pathology Breakdown Data by Type

- primarily split into

- Stent

- PTA Balloon

ICAD (Intracranial Atherosclerotic Disease) Pathology Breakdown Data by Application

- Hospital

- Clinic

- Other

Covid-19 Impact on Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue
1.4 Market Analysis by Type
1.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 primarily split into
1.4.3 Stent
1.4.4 PTA Balloon
1.5 Market by Application
1.5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Impact
1.6.1 How the Covid-19 is Affecting the ICAD (Intracranial Atherosclerotic Disease) Pathology Industry
1.6.1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and ICAD (Intracranial Atherosclerotic Disease) Pathology Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for ICAD (Intracranial Atherosclerotic Disease) Pathology Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Perspective (2015-2026)
2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Growth Trends by Regions
2.2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Share by Regions (2015-2020)
2.2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Growth Strategy
2.3.6 Primary Interviews with Key ICAD (Intracranial Atherosclerotic Disease) Pathology Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Players by Market Size
3.1.1 Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Players by Revenue (2015-2020)
3.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Players (2015-2020)
3.1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Concentration Ratio
3.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in 2019
3.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Players Head office and Area Served
3.4 Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Product Solution and Service
3.5 Date of Enter into ICAD (Intracranial Atherosclerotic Disease) Pathology Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Size by Type (2015-2020)
4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Type (2021-2026)
5 ICAD (Intracranial Atherosclerotic Disease) Pathology Breakdown Data by Application (2015-2026)
5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (2015-2020)
5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2015-2020)
6.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Players in North America (2019-2020)
6.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (2015-2020)
6.4 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (2015-2020)
7 Europe
7.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2015-2020)
7.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Players in Europe (2019-2020)
7.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (2015-2020)
7.4 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (2015-2020)
8 China
8.1 China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2015-2020)
8.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Players in China (2019-2020)
8.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (2015-2020)
8.4 China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (2015-2020)
9 Japan
9.1 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2015-2020)
9.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Players in Japan (2019-2020)
9.3 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (2015-2020)
9.4 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2015-2020)
10.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (2015-2020)
10.4 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (2015-2020)
11 India
11.1 India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2015-2020)
11.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Players in India (2019-2020)
11.3 India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (2015-2020)
11.4 India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2015-2020)
12.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Players in Central & South America (2019-2020)
12.3 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (2015-2020)
12.4 Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Stryker
13.1.1 Stryker Company Details
13.1.2 Stryker Business Overview and Its Total Revenue
13.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Introduction
13.1.4 Stryker Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2015-2020))
13.1.5 Stryker Recent Development
13.2 Balt
13.2.1 Balt Company Details
13.2.2 Balt Business Overview and Its Total Revenue
13.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Introduction
13.2.4 Balt Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2015-2020)
13.2.5 Balt Recent Development
13.3 TERUMO
13.3.1 TERUMO Company Details
13.3.2 TERUMO Business Overview and Its Total Revenue
13.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Introduction
13.3.4 TERUMO Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2015-2020)
13.3.5 TERUMO Recent Development
13.4 MicroPort
13.4.1 MicroPort Company Details
13.4.2 MicroPort Business Overview and Its Total Revenue
13.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Introduction
13.4.4 MicroPort Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2015-2020)
13.4.5 MicroPort Recent Development
13.5 Acandis
13.5.1 Acandis Company Details
13.5.2 Acandis Business Overview and Its Total Revenue
13.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Introduction
13.5.4 Acandis Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2015-2020)
13.5.5 Acandis Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Key Market Segments
Table 2. Key Players Covered: Ranking by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue
Table 3. Ranking of Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of primarily split into
Table 6. Key Players of Stent
Table 7. Key Players of PTA Balloon
Table 8. COVID-19 Impact Global Market: (Four ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for ICAD (Intracranial Atherosclerotic Disease) Pathology Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for ICAD (Intracranial Atherosclerotic Disease) Pathology Players to Combat Covid-19 Impact
Table 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Regions (2015-2020)
Table 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Growth Strategy
Table 23. Main Points Interviewed from Key ICAD (Intracranial Atherosclerotic Disease) Pathology Players
Table 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Players (2015-2020) (Million US$)
Table 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Players (2015-2020)
Table 26. Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology as of 2019)
Table 27. Global ICAD (Intracranial Atherosclerotic Disease) Pathology by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Product Solution and Service
Table 30. Date of Enter into ICAD (Intracranial Atherosclerotic Disease) Pathology Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (2015-2020) (Million US$)
Table 33. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Share by Type (2015-2020)
Table 34. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2021-2026)
Table 35. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Share by Application (2015-2020)
Table 36. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (2015-2020) (Million US$)
Table 37. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Share by Application (2021-2026)
Table 38. North America Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2019-2020) (Million US$)
Table 39. North America Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share (2019-2020)
Table 40. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (2015-2020) (Million US$)
Table 41. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Type (2015-2020)
Table 42. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (2015-2020) (Million US$)
Table 43. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Application (2015-2020)
Table 44. Europe Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share (2019-2020)
Table 46. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (2015-2020) (Million US$)
Table 47. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Type (2015-2020)
Table 48. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (2015-2020) (Million US$)
Table 49. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Application (2015-2020)
Table 50. China Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2019-2020) (Million US$)
Table 51. China Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share (2019-2020)
Table 52. China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (2015-2020) (Million US$)
Table 53. China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Type (2015-2020)
Table 54. China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (2015-2020) (Million US$)
Table 55. China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Application (2015-2020)
Table 56. Japan Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share (2019-2020)
Table 58. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (2015-2020) (Million US$)
Table 59. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Type (2015-2020)
Table 60. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (2015-2020) (Million US$)
Table 61. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share (2019-2020)
Table 64. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Type (2015-2020)
Table 66. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Application (2015-2020)
Table 68. India Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2019-2020) (Million US$)
Table 69. India Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share (2019-2020)
Table 70. India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (2015-2020) (Million US$)
Table 71. India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Type (2015-2020)
Table 72. India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (2015-2020) (Million US$)
Table 73. India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Application (2015-2020)
Table 74. Central & South America Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share (2019-2020)
Table 76. Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Type (2015-2020)
Table 78. Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Application (2015-2020)
Table 80. Stryker Company Details
Table 81. Stryker Business Overview
Table 82. Stryker Product
Table 83. Stryker Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2015-2020) (Million US$)
Table 84. Stryker Recent Development
Table 85. Balt Company Details
Table 86. Balt Business Overview
Table 87. Balt Product
Table 88. Balt Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2015-2020) (Million US$)
Table 89. Balt Recent Development
Table 90. TERUMO Company Details
Table 91. TERUMO Business Overview
Table 92. TERUMO Product
Table 93. TERUMO Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2015-2020) (Million US$)
Table 94. TERUMO Recent Development
Table 95. MicroPort Company Details
Table 96. MicroPort Business Overview
Table 97. MicroPort Product
Table 98. MicroPort Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2015-2020) (Million US$)
Table 99. MicroPort Recent Development
Table 100. Acandis Company Details
Table 101. Acandis Business Overview
Table 102. Acandis Product
Table 103. Acandis Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2015-2020) (Million US$)
Table 104. Acandis Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Type: 2020 VS 2026
Figure 2. primarily split into Features
Figure 3. Stent Features
Figure 4. PTA Balloon Features
Figure 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. ICAD (Intracranial Atherosclerotic Disease) Pathology Report Years Considered
Figure 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Regions: 2020 VS 2026
Figure 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Players in 2019
Figure 15. Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology as of 2019
Figure 16. The Top 10 and 5 Players Market Share by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in 2019
Figure 17. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Stryker Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Stryker Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2015-2020)
Figure 26. Balt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Balt Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2015-2020)
Figure 28. TERUMO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. TERUMO Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2015-2020)
Figure 30. MicroPort Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. MicroPort Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2015-2020)
Figure 32. Acandis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Acandis Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Business (2015-2020)
Figure 34. Bottom-up and Top-down Approaches for This Report
Figure 35. Data Triangulation
Figure 36. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs